Rates of Retreatment after Transvenous Embolization of CSF-Venous Fistulas in Spontaneous Intracranial Hypotension
- 1From the Department of Radiology (D.S., N.T.B., T.J.A., J.W., L.G., A.A.M., M.D.M., P.G.K.), Duke University Medical Center, Durham, North Carolina
- 2Duke University School of Medicine (S.C.), Durham, North Carolina
Abstract
BACKGROUND AND PURPOSE: CSF-venous fistulas (CVF) cause spontaneous intracranial hypotension (SIH) and can be treated with transvenous embolization (TVE). Although TVE has been shown to result in substantial symptomatic improvement, some patients may require retreatment. The purpose of this study was to clarify the rate, anatomic location, and timing of CVF recurrence/retreatment after TVE. MATERIALS AND METHODS: This study is a single-center, retrospective cohort of consecutive patients with CVF who were treated with TVE. The rate of retreatment after TVE was determined. In addition, timing of symptom onset and location of recurrent CVF was recorded. RESULTS: One hundred consecutive patients (65% women, mean age 59.3 years) with 105 CVFs treated with TVE were included. Overall, 23% (23/100) of patients required retreatment due to persistence or recurrence of symptoms. Most retreatment patients (74%; 17/23) had persistent or recurrent symptoms within 3 months after TVE. Approximately one-third of patients needing retreatment (35%; 8/23) had a CVF at the same site and level as the initial CVF after having been embolized. Approximately one-third (30%; 7/23) had a recurrent CVF adjacent to the initial CVF (defined as 1 level above, 1 level below, or at the same level but on the contralateral side). The remaining patients (35%; 8/23) had a CVF remote from the original fistula site. CONCLUSIONS: Approximately 23% of patients with CVF that are treated with TVE will require retreatment. Symptom recurrence is most common within 3 months after initial treatment. Recurrence can occur due to local treatment failure or development of collateral drainage pathways, but a substantial proportion of patients develop de novo CVFs remote from the initial treatment site. These findings can be used to counsel patients and to manage treatment expectations.
Related
- Spontaneous Intracranial Hypotension with Bilateral Subdural Haematomas and Posterior Cerebral Artery Infarcts with Delayed Epidural Blood Patch Response: A Case Report
- Spontaneous Intracranial Hypotension Presenting With Acute Orthostatic Headache: A Case Report
- Age-related differences in clinical manifestations, neuroimaging features, and treatment of spontaneous intracranial hypotension: a retrospective cohort study.
- Evaluation of the C1-C2 False Localizing Sign in Spontaneous Intracranial Hypotension: Prevalence and Clinical Insights
- Recommendations for the Management of Spontaneous Intracranial Hypotension With Spinal Longitudinal Epidural CSF Collection
BibTeX
@article{schartz2026rates,
title = {{Rates of Retreatment after Transvenous Embolization of CSF-Venous Fistulas in Spontaneous Intracranial Hypotension}},
author = {Derrek Schartz and Nicholas T. Befera and Timothy J. Amrhein and Soren Christensen and Jay Willhite and Linda Gray and Ajay A. Madhavan and Michael D. Malinzak and Peter G. Kranz},
journal = {AJNR: American Journal of Neuroradiology},
year = {2026},
month = nov,
doi = {10.3174/ajnr.a9327},
url = {https://doi.org/10.3174/ajnr.a9327},
note = {CC BY},
}
RIS
TY - JOUR
TI - Rates of Retreatment after Transvenous Embolization of CSF-Venous Fistulas in Spontaneous Intracranial Hypotension
AU - Derrek Schartz
AU - Nicholas T. Befera
AU - Timothy J. Amrhein
AU - Soren Christensen
AU - Jay Willhite
AU - Linda Gray
AU - Ajay A. Madhavan
AU - Michael D. Malinzak
AU - Peter G. Kranz
PY - 2026
DA - 2026/11/06
JO - AJNR: American Journal of Neuroradiology
DO - 10.3174/ajnr.a9327
UR - https://doi.org/10.3174/ajnr.a9327
AB - BACKGROUND AND PURPOSE: CSF-venous fistulas (CVF) cause spontaneous intracranial hypotension (SIH) and can be treated with transvenous embolization (TVE). Although TVE has been shown to result in substantial symptomatic improvement, some patients may require retreatment. The purpose of this study was to clarify the rate, anatomic location, and timing of CVF recurrence/retreatment after TVE. MATERIALS AND METHODS: This study is a single-center, retrospective cohort of consecutive patients with CVF who were treated with TVE. The rate of retreatment after TVE was determined. In addition, timing of symptom onset and location of recurrent CVF was recorded. RESULTS: One hundred consecutive patients (65% women, mean age 59.3 years) with 105 CVFs treated with TVE were included. Overall, 23% (23/100) of patients required retreatment due to persistence or recurrence of symptoms. Most retreatment patients (74%; 17/23) had persistent or recurrent symptoms within 3 months after TVE. Approximately one-third of patients needing retreatment (35%; 8/23) had a CVF at the same site and level as the initial CVF after having been embolized. Approximately one-third (30%; 7/23) had a recurrent CVF adjacent to the initial CVF (defined as 1 level above, 1 level below, or at the same level but on the contralateral side). The remaining patients (35%; 8/23) had a CVF remote from the original fistula site. CONCLUSIONS: Approximately 23% of patients with CVF that are treated with TVE will require retreatment. Symptom recurrence is most common within 3 months after initial treatment. Recurrence can occur due to local treatment failure or development of collateral drainage pathways, but a substantial proportion of patients develop de novo CVFs remote from the initial treatment site. These findings can be used to counsel patients and to manage treatment expectations.
SN - 0195-6108
SN - 1936-959X
ER -